Pharmacoeconomic Evaluation, Cost Minimization Analysis of Anti-Diabetic Therapy in Gujarat

Journal Title: International Journal of Medical Research & Health Sciences - Year 2016, Vol 5, Issue 3

Abstract

Economic burden of DM was approximated $ 132 billion in 2002. 55 patients with DM were recruited. Their clinical information was analyzed for most commonly and most costly prescribed drug molecule. Three brands of both drugs were selected and laboratory analysis was done for all the selected brands to compare the bioequivalence. For the rest of drugs prescribed, the prices were compared using published resources. Metformin 500 mg was the most commonly prescribed drug. Sitagliptin 50 mg was the costliest drug prescribed. Glycomet, Glyciphage and Forson were the brands of Metformin, Januvia and Zeta were the brands of Sitagliptin, selected for lab analysis. The drug content for metformin in Glycomet (100%), Glyciphage (99.24%) and Forson (98.95%) for Sitagliptin, Januvia (100%) and Zeta (102.43%) was nearly same. The price variation of Metformin was found to be 94.83% and that of Sitagliptin was found to be 174.5%. Since it is evident that same drug molecule varying in costs has same drug strength content they would produce similar clinical outcomes. This concludes that cheaper drugs can be prescribed to patients reducing the health-economic burden on diabetic patients.

Authors and Affiliations

Shah Jainam V.

Keywords

Related Articles

Determinants of lost to follow up during treatment among tuberculosis patients in Delhi

Tuberculosis ranks as the second leading cause of death from an infectious disease worldwide, after the human immunodeficiency virus. With more than two million cases of tuberculosis, India remains on top in the list of...

Soft tissue cephalometric norms in Iranian normal subjects

Soft tissue analysis has been proposed by many authors as a reliable guide in treatment planning. Thus establishing population norms is an important issue in orthodontic treatment. The aim of this study was to determine...

Impact of pharmaceutical care activities on diabetic patients at a private corporate hospital

Diabetes is a disease that desperately needs more pharmacist involvement. Pharmaceutical care and expanded role of pharmacist are associated with many positive diabetes related outcomes, including improved clinical measu...

Performance Evaluation Factors: Designing an Instrument for NationalHealth Network in Iran

As a systematic process for gathering and analyzing data, performance evaluation could be used as a valid method to highlight levels of success and to identify strength and weakness of ongoing programs. The aim of the pr...

Comparative efficacy of MIRU-VNTR and IS 6110-RFLP for differentiation of Mycobacterium tuberculosis isolates

The aim of this study was To characterize Mycobacterium tuberculosis isolates by MIRU-VNTR typing and IS 6110 – RFLP and to compare the efficiency of MIRU-VNTR typing and IS 6110 – RFLP in discriminating Mycobacterium tu...

Download PDF file
  • EP ID EP247560
  • DOI -
  • Views 130
  • Downloads 0

How To Cite

Shah Jainam V. (2016). Pharmacoeconomic Evaluation, Cost Minimization Analysis of Anti-Diabetic Therapy in Gujarat. International Journal of Medical Research & Health Sciences, 5(3), 34-43. https://europub.co.uk/articles/-A-247560